Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis

Figure 5 Effects of partially hydrolyzed guar gum on intestinal permeability in the non-alcoholic fatty liver disease model. Lumen-to-blood clearance of fluorescein isothiocyanate-conjugated dextran was evaluated by injection into the duodenum and collection of blood after 60 min. Fluorescence intensity in the serum was measured with a spectrofluorometer. Data represent the mean ± SD of seven mice. ^aP < 0.05 significant differences compared to the control group; ^bP < 0.05 significant differences between the 2 selected groups. NAFLD: Non-alcoholic fatty liver disease; PHGG: Partially hydrolyzed guar gum.